Exascale Labs Holdings Inc. XLAB
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.75M | 3.54M | 3.26M | 2.54M | 1.86M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.75M | 3.54M | 3.26M | 2.54M | 1.86M |
| Cost of Revenue | 3.17M | 3.02M | 2.71M | 2.08M | 1.65M |
| Gross Profit | 586.90K | 520.50K | 551.00K | 456.80K | 213.10K |
| SG&A Expenses | 573.40K | 370.80K | 294.60K | 357.10K | 481.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.98M | 4.53M | 3.87M | 3.12M | 2.51M |
| Operating Income | -1.22M | -988.00K | -608.70K | -582.40K | -646.50K |
| Income Before Tax | -2.63M | -3.77M | -1.52M | -1.48M | -1.54M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.63M | -3.77M | -1.52M | -1.48M | -1.54M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.63M | -3.77M | -1.52M | -1.48M | -1.54M |
| EBIT | -1.22M | -988.00K | -608.70K | -582.40K | -646.50K |
| EBITDA | -1.22M | -986.40K | -606.60K | -580.80K | -644.90K |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |